809 related articles for article (PubMed ID: 25636720)
1. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
Ketha H; Wadams H; Lteif A; Singh RJ
J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia, hypervitaminosis A and 3-epi-25-OH-D3 levels after consumption of an "over the counter" vitamin D remedy. a case report.
Granado-Lorencio F; Rubio E; Blanco-Navarro I; Pérez-Sacristán B; Rodríguez-Pena R; García López FJ
Food Chem Toxicol; 2012 Jun; 50(6):2106-8. PubMed ID: 22426357
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
5. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
[TBL] [Abstract][Full Text] [Related]
6. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
[TBL] [Abstract][Full Text] [Related]
7. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia, nephrolithiasis, and hypervitaminosis D precipitated by supplementation in a susceptible individual.
Haridas K; Holick MF; Burmeister LA
Nutrition; 2020 Jun; 74():110754. PubMed ID: 32222584
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben PJ; Singh RJ; Kumar R
Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
[TBL] [Abstract][Full Text] [Related]
10. Analysis of vitamin D
Kowalska E; Rola R; Wójcik M; Łaszcz N; Płudowski P; Wierzbicka A; Janiec A; Książyk J; Halat P; Ciara E; Obrycki Ł; Pronicka E; Litwin M
J Steroid Biochem Mol Biol; 2021 Apr; 208():105824. PubMed ID: 33516786
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D toxicity due to a commonly available "over the counter" remedy from the Dominican Republic.
Lowe H; Cusano NE; Binkley N; Blaner WS; Bilezikian JP
J Clin Endocrinol Metab; 2011 Feb; 96(2):291-5. PubMed ID: 21123442
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D intoxication due to an erroneously manufactured dietary supplement in seven children.
Kara C; Gunindi F; Ustyol A; Aydin M
Pediatrics; 2014 Jan; 133(1):e240-4. PubMed ID: 24298009
[TBL] [Abstract][Full Text] [Related]
13. Serum 24,25-dihydroxyvitamin D
Graeff-Armas LA; Kaufmann M; Lyden E; Jones G
Clin Nutr; 2018 Jun; 37(3):1041-1045. PubMed ID: 28506446
[TBL] [Abstract][Full Text] [Related]
14. CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.
Rousseau-Nepton I; Jones G; Schlingmann K; Kaufmann M; Zuijdwijk CS; Khatchadourian K; Gupta IR; Pacaud D; Pinsk MN; Mokashi A; Nour MA; Alexander RT; Rodd CJ
Horm Res Paediatr; 2021; 94(3-4):124-132. PubMed ID: 34320495
[TBL] [Abstract][Full Text] [Related]
15. Calcioic acid: In vivo detection and quantification of the terminal C24-oxidation product of 25-hydroxyvitamin D
Kaufmann M; Martineau C; Arabian A; Traynor M; St-Arnaud R; Jones G
J Steroid Biochem Mol Biol; 2019 Apr; 188():23-28. PubMed ID: 30553931
[TBL] [Abstract][Full Text] [Related]
16. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter CS; Weiskopf AS; Vouros P; Sasso GJ; Uskokovic MR; Wang G; Reddy GS
J Cell Biochem; 2005 Oct; 96(3):569-78. PubMed ID: 16088954
[TBL] [Abstract][Full Text] [Related]
17. Placental vitamin D metabolism and its associations with circulating vitamin D metabolites in pregnant women.
Park H; Wood MR; Malysheva OV; Jones S; Mehta S; Brannon PM; Caudill MA
Am J Clin Nutr; 2017 Dec; 106(6):1439-1448. PubMed ID: 29021285
[No Abstract] [Full Text] [Related]
18. The Effect of a Single High Dose of Vitamin D on Serum Levels of Its Metabolites in the Elderly.
Leszczyńska D; Szatko A; Kowalski K; Raczkiewicz D; Ostrowska M; Misiorowski W; Zgliczyński W; Glinicki P
Front Biosci (Landmark Ed); 2022 Oct; 27(10):289. PubMed ID: 36336861
[TBL] [Abstract][Full Text] [Related]
19. [Hypervitaminosis D].
Morita R; Yamamoto I; Takada M; Ohnaka Y; Yuu I
Nihon Rinsho; 1993 Apr; 51(4):984-8. PubMed ID: 8483281
[TBL] [Abstract][Full Text] [Related]
20. Persistent hypercalcaemia associated with two pathogenic variants in the
Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
